CN Patent

CN104306350A — 包含尼罗替尼或其盐的药物组合物

Assigned to Novartis AG · Expires 2015-01-28 · 11y expired

What this patent protects

本发明涉及包含尼罗替尼或其盐的药物组合物。本发明涉及药物组合物，特别是胶囊剂，该胶囊剂包含颗粒，所述的颗粒包含尼罗替尼或其盐以及至少一种可药用赋形剂。颗粒可以通过湿法制粒方法制备。

USPTO Abstract

本发明涉及包含尼罗替尼或其盐的药物组合物。本发明涉及药物组合物，特别是胶囊剂，该胶囊剂包含颗粒，所述的颗粒包含尼罗替尼或其盐以及至少一种可药用赋形剂。颗粒可以通过湿法制粒方法制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN104306350A
Jurisdiction
CN
Classification
—
Expires
2015-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.